Farzin Haque

Stock Analyst at Jefferies

(1.66)
# 3,568
Out of 5,134 analysts
12
Total ratings
41.7%
Success rate
0.3%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Farzin Haque

Vor Biopharma
Sep 9, 2026
Reiterated: Buy
Price Target: $50 → $48
Current: $19.42
Upside: +147.17%
Relmada Therapeutics
Dec 21, 2025
Initiated Coverage: Buy
Price Target: $9
Current: $4.21
Upside: +113.78%
Vera Therapeutics
Nov 26, 2025
Reiterated: Buy
Price Target: $57 → $45
Current: $28.10
Upside: +60.14%
Rigel Pharmaceuticals
Nov 5, 2025
Upgraded: Buy
Price Target: $42
Current: $44.46
Upside: n/a
Nuvation Bio
Sep 29, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $3.99
Upside: n/a
Werewolf Therapeutics
Aug 4, 2025
Initiated Coverage: Buy
Price Target: $4
Current: $0.9803
Upside: n/a
Pyxis Oncology
Mar 18, 2025
Reiterated: Buy
Price Target: $10 → $6
Current: $1.58
Upside: n/a